HALF YEARLY RESULTS
Jubilant Pharmova Ltd.
BSE
Jun 02, 04:01
1166.90
-5.45 ( -0.46%)
Volume
15899
Prev. Close
1172.35
Open Price
1179.45
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Jun 02, 03:53
1169.70
-4.10 ( -0.35%)
Volume
307399
Prev. Close
1173.80
Open Price
1173.80
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
1169.70 (55)
You can view the
Halfyearly Results
for the last 5 years.
|
ISIN No
|
INE700A01033
|
Market Cap. ( ₹ in Cr. )
|
18631.11
|
P/BV
|
3.14
|
Book Value ( ₹ )
|
372.96
|
|
BSE Code
|
530019
|
52 Week High/Low ( ₹ )
|
1310/617
|
FV/ML
|
1/1
|
P/E(X)
|
22.20
|
|
NSE Code
|
JUBLPHARMAEQ
|
Book Closure
|
25/07/2025
|
EPS ( ₹ )
|
52.70
|
Div Yield (%)
|
0.43
|
(₹ in Crs.)
| Net Sales/Income from operations | 408.70 | 332.40 | 371.90 | 403.70 | 372.13 |
| Other Operating Income | 4.60 | 0.00 | 9.10 | 0.00 | 10.45 |
| Total Income From Operations | 413.30 | 332.40 | 381.00 | 403.70 | 382.58 |
| | | | | | |
| EXPENDITURE | | | | | |
| Consumption of Raw Materials | 154.80 | 127.70 | 143.20 | 166.80 | 207.04 |
| Purchase of Traded Goods | 0.00 | 0.00 | 2.40 | 4.10 | 7.40 |
| Increase/Decrease in Stocks | 2.10 | -8.80 | 18.10 | 20.90 | -29.27 |
| Employees Cost | 102.90 | 100.10 | 96.40 | 93.60 | 82.98 |
| Depreciation | 26.70 | 26.40 | 25.00 | 23.30 | 22.96 |
| Other Expenses | 116.50 | 118.30 | 109.40 | 113.30 | 114.14 |
| Total Expenses | 403.00 | 363.70 | 394.50 | 422.00 | 405.25 |
| | | | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 10.30 | -31.30 | -13.50 | -18.30 | -22.67 |
| Other Income | 36.30 | 63.30 | 69.10 | 34.30 | 21.53 |
| P/L Before Interest, Excpt. Items & Tax | 46.60 | 32.00 | 55.60 | 16.00 | -1.14 |
| Interest | 14.40 | 15.40 | 16.40 | 13.50 | 11.23 |
| P/L Before Exceptional Items & Tax | 32.20 | 16.60 | 39.20 | 2.50 | -12.37 |
| Exceptional Items | 0.00 | -11.20 | 0.00 | 0.00 | 0.00 |
| P/L Before Tax | 32.20 | 5.40 | 39.20 | 2.50 | -12.37 |
| Tax | 13.30 | 5.10 | 9.10 | 1.00 | 24.38 |
| P/L After Tax from Ordinary Activities | 18.90 | 0.30 | 30.10 | 1.50 | -36.75 |
| Net Profit/Loss For the Period | 18.90 | 0.30 | 30.10 | 1.50 | -36.75 |
| | | | | | |
| Equity Share Capital | 15.90 | 15.90 | 15.90 | 15.90 | 15.93 |
| EPS Before Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 1.19 | 0.02 | 1.89 | 0.09 | -2.31 |
| Diluted EPS (Rs.) | 1.19 | 0.02 | 1.89 | 0.09 | (2.31) |
| EPS After Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 1.19 | 0.02 | 1.89 | 0.09 | -2.31 |
| Diluted EPS (Rs.) | 0.00 | 0.02 | 0.00 | 0.09 | 0.00 |
| | | | | | |
| PBITOE Margin (%) | 2.49 | -9.41 | -3.54 | -4.53 | -5.92 |
| PBTE Margin (%) | 7.79 | 4.99 | 10.28 | 0.61 | -3.23 |
| PBT Margin (%) | 7.79 | 1.62 | 10.28 | 0.61 | -3.23 |
| PAT Margin (%) | 4.57 | 0.09 | 7.90 | 0.37 | -9.60 |